La traduction de cette page est expérimentale et en cours de développement. N'hésitez pas à vos !

Shrenik Croissance future

Future contrôle des critères 0/6

Nous ne disposons actuellement pas d'une couverture d'analyste suffisante pour prévoir la croissance et les revenus de Shrenik.

Informations clés

n/a

Taux de croissance des bénéfices

n/a

Taux de croissance du BPA

Trade Distributors croissance des bénéfices	8.8%
Taux de croissance des recettes	n/a
Rendement futur des capitaux propres	n/a
Couverture par les analystes	None
Dernière mise à jour	n/a

Mises à jour récentes de la croissance future

Pas de mise à jour

Recent updates

Should You Be Worried About Shrenik Limited's (NSE:SHRENIK) 1.5% Return On Equity?

Mar 07

Here's Why Shrenik (NSE:SHRENIK) Is Weighed Down By Its Debt Load

Feb 15

Estimating The Intrinsic Value Of Shrenik Limited (NSE:SHRENIK)

Jan 28

Is Shrenik (NSE:SHRENIK) Likely To Turn Things Around?

Jan 11

Should Shrenik Limited (NSE:SHRENIK) Be Part Of Your Dividend Portfolio?

Dec 14

Dans cette section, nous présentons généralement des projections de croissance du chiffre d'affaires et des bénéfices basées sur les estimations consensuelles d'analystes professionnels afin d'aider les investisseurs à comprendre la capacité de l'entreprise à générer des bénéfices. Mais comme Shrenik n'a pas fourni suffisamment de données passées et n'a pas de prévisions d'analystes, ses bénéfices futurs ne peuvent pas être calculés de manière fiable en extrapolant les données passées ou en utilisant les prévisions des analystes.

Il s'agit d'une situation assez rare car 97% des entreprises couvertes par SimplyWall St disposent de données financières passées.

Prévisions de croissance des bénéfices et des revenus

NSEI:SHRENIK - Estimations futures des analystes et données financières antérieures (INR Millions )
Date	Recettes	Les revenus	Flux de trésorerie disponible	Cash from Op	Moy. Nombre d'analystes
6/30/2024	288	-616	N/A	N/A	N/A
3/31/2024	342	-1,089	-19	1,252	N/A
12/31/2023	402	-34	N/A	N/A	N/A
6/30/2023	452	-481	N/A	N/A	N/A
3/31/2023	486	2	468	469	N/A
12/31/2022	482	-11	N/A	N/A	N/A
9/30/2022	461	-28	-94	-94	N/A
6/30/2022	417	-101	N/A	N/A	N/A
3/31/2022	638	-144	-77	-77	N/A
12/31/2021	1,356	-116	N/A	N/A	N/A
9/30/2021	1,721	-117	98	98	N/A
6/30/2021	3,390	-31	N/A	N/A	N/A
3/31/2021	3,637	-15	269	269	N/A
12/31/2020	4,198	11	N/A	N/A	N/A
9/30/2020	5,759	53	231	235	N/A
6/30/2020	6,250	61	N/A	N/A	N/A
3/31/2020	7,956	113	85	104	N/A
12/31/2019	8,771	140	N/A	N/A	N/A
9/30/2019	8,956	134	-369	-301	N/A
6/30/2019	8,683	120	N/A	N/A	N/A
3/31/2019	8,368	111	-247	-181	N/A
12/31/2018	7,743	94	N/A	N/A	N/A
9/30/2018	7,131	93	N/A	N/A	N/A
6/30/2018	6,532	86	N/A	N/A	N/A
3/31/2018	5,932	79	N/A	-469	N/A
3/31/2017	4,277	42	N/A	-131	N/A
3/31/2016	3,292	29	N/A	-75	N/A
3/31/2015	2,657	10	N/A	60	N/A
3/31/2014	2,131	10	N/A	-73	N/A

Prévisions de croissance des analystes

Taux de revenus par rapport au taux d'épargne: Données insuffisantes pour déterminer si la croissance des bénéfices prévue de SHRENIK est supérieure au taux d'épargne ( 6.7% ).

Bénéfices vs marché: Données insuffisantes pour déterminer si les bénéfices de SHRENIK devraient croître plus rapidement que le marché Indian

Croissance élevée des bénéfices: Données insuffisantes pour déterminer si les bénéfices de SHRENIK devraient augmenter de manière significative au cours des 3 prochaines années.

Chiffre d'affaires vs marché: Données insuffisantes pour déterminer si les revenus de SHRENIK devraient croître plus rapidement que le marché Indian.

Croissance élevée des revenus: Données insuffisantes pour déterminer si les revenus de SHRENIK devraient croître plus rapidement que 20% par an.

Prévisions de croissance du bénéfice par action

Rendement futur des capitaux propres

ROE futur: Données insuffisantes pour déterminer si le retour sur capitaux propres de SHRENIK devrait être élevé dans 3 ans

Shrenik Croissance future

Future contrôle des critères 0/6

Informations clés

Mises à jour récentes de la croissance future

Recent updates

First quarter 2025 earnings released

Chairman & MD recently sold ₹181k worth of stock

Chairman & MD recently sold ₹728k worth of stock

Insufficient new directors

Shrenik Limited Appoints Nirav Harshvadan Zaveri as Independent Director

Full year 2024 earnings released

Chairman & MD recently sold ₹6.5m worth of stock

Chairman & MD recently sold ₹295k worth of stock

Chairman & MD recently sold ₹1.1m worth of stock

Chairman & MD recently sold ₹542k worth of stock

Chairman & MD recently sold ₹207k worth of stock

Chairman & MD recently sold ₹543k worth of stock

Chairman & MD recently sold ₹544k worth of stock

Third quarter 2024 earnings released

Chairman & MD recently sold ₹626k worth of stock

Chairman & MD recently sold ₹370k worth of stock

Chairman & MD recently sold ₹1.0m worth of stock

Chairman & MD recently sold ₹1.7m worth of stock

Chairman & MD recently sold ₹973k worth of stock

Is Shrenik (NSE:SHRENIK) A Risky Investment?

Chairman & MD recently sold ₹935k worth of stock

First quarter 2024 earnings released: ₹0.77 loss per share (vs ₹0.01 profit in 1Q 2023)

Chairman & MD recently sold ₹1.3m worth of stock

Chairman & MD recently sold ₹1.2m worth of stock

Full year 2023 earnings released: EPS: ₹0.004 (vs ₹0.23 loss in FY 2022)

Chairman & MD recently sold ₹1.1m worth of stock

Is Shrenik (NSE:SHRENIK) Using Debt Sensibly?

Chairman & MD recently sold ₹108k worth of stock

Chairman & MD recently sold ₹2.4m worth of stock

Chairman & MD recently sold ₹2.5m worth of stock

Chairman & MD recently sold ₹1.6m worth of stock

Third quarter 2023 earnings released: EPS: ₹0.01 (vs ₹0.02 loss in 3Q 2022)

Is Shrenik (NSE:SHRENIK) A Risky Investment?

Chairman & MD recently sold ₹425k worth of stock

Chairman & MD recently sold ₹481k worth of stock

Chairman & MD recently sold ₹140k worth of stock

Chairman & MD recently sold ₹805k worth of stock

Second quarter 2023 earnings released: EPS: ₹0.03 (vs ₹0.09 loss in 2Q 2022)

Chairman & MD recently sold ₹519k worth of stock

Is Shrenik (NSE:SHRENIK) A Risky Investment?

Shrenik Limited, Annual General Meeting, Sep 29, 2022

Chairman & MD recently sold ₹774k worth of stock

Chairman & MD recently sold ₹957k worth of stock

Chairman & MD recently sold ₹1.2m worth of stock

First quarter 2023 earnings released: EPS: ₹0.01 (vs ₹0.06 loss in 1Q 2022)

Chairman & MD recently sold ₹190k worth of stock

Chairman & MD recently sold ₹335k worth of stock

Chairman & MD recently sold ₹233k worth of stock

Be Wary Of Shrenik (NSE:SHRENIK) And Its Returns On Capital

Full year 2022 earnings released: ₹0.23 loss per share (vs ₹0.024 loss in FY 2021)

Investors Could Be Concerned With Shrenik's (NSE:SHRENIK) Returns On Capital

Third quarter 2022 earnings: Revenues and EPS in line with analyst expectations

Chairman & MD recently sold ₹12m worth of stock

Shrenik (NSE:SHRENIK) Use Of Debt Could Be Considered Risky

Whole Time Director recently sold ₹9.9m worth of stock

Investors Could Be Concerned With Shrenik's (NSE:SHRENIK) Returns On Capital

Second quarter 2022 earnings released

Chairman & MD recently sold ₹3.6m worth of stock

Insider recently sold ₹782k worth of stock

Board Member recently sold ₹8.5m worth of stock

Does Shrenik (NSE:SHRENIK) Have A Healthy Balance Sheet?

First quarter 2022 earnings released: ₹0.06 loss per share (vs ₹0.03 loss in 1Q 2021)

Independent Director Manali Shah has left the company

Insider recently sold ₹744k worth of stock

Insider recently sold ₹142k worth of stock

Full year 2021 earnings released: ₹0.02 loss per share (vs ₹0.19 profit in FY 2020)

Shrenik's (NSE:SHRENIK) Returns On Capital Not Reflecting Well On The Business

Investor sentiment improved over the past week

Insider recently sold ₹1.1m worth of stock

What Makes Shrenik Limited (NSE:SHRENIK) A Great Dividend Stock?

Insider recently sold ₹332k worth of stock

Investor sentiment deteriorated over the past week

Should You Be Worried About Shrenik Limited's (NSE:SHRENIK) 1.5% Return On Equity?

Insider recently sold ₹7.1m worth of stock

Insider recently sold ₹628k worth of stock